Artificial Intelligence for Early Drug Discovery Part 2 Icon

Cambridge Healthtech Institute’s 5th Annual

Artificial Intelligence for Early Drug Discovery - Part 2

Innovative Use of Computational Tools for Finding New Targets and Drugs

APRIL 12 - 13, 2023

 

The Artificial Intelligence for Early Drug Discovery conference brings together a diverse group of experts from chemistry, target discovery, pharmacology, and bioinformatics, to talk about the increasing use of computational tools, artificial intelligence (AI) models, machine learning (ML) algorithms, and data mining in preclinical drug development. The talks will highlight the opportunities and limitations of AI/ML-driven decision-making, using relevant case studies and research findings. The first part of the conference will focus on how AI/ML can help in drug design, hit identification, lead optimization, PK/PD predictions, and early safety assessments. The second part will focus on emerging computational tools and models to identify new drug targets, prioritize compounds for development and to help drive niche applications, such as predictions for targeted protein degradation.






Please click here to return to the agenda for Artificial Intelligence for Early Drug Discovery - Part 1


For more details on the conference, please contact:

Tanuja Koppal, PhD

Senior Conference Director

Cambridge Healthtech Institute

Email: tkoppal@healthtech.com

 

For sponsorship information, please contact:

Kristin Skahan

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5431

Email: kskahan@healthtech.com